1

Romlusevimab (BRII-198): A New Hope for Self-Reactive Condition?

News Discuss 
Recent studies indicate that {Romlusevimab | BRII-198 | this investigational antibody ) offers a potential strategy for managing a range of autoimmune ailments . Targeting {BAFF | B-cell related factor | https://romlusevimabantisarscov2941368.wikicorrespondence.com/user

Comments

    No HTML

    HTML is disabled


Who Upvoted this Story